Related references
Note: Only part of the references are listed.Angiotensin-(1-7) infusion is associated with increased blood pressure and adverse cardiac remodelling in rats with subtotal nephrectomy
Elena Velkoska et al.
CLINICAL SCIENCE (2011)
ACE2: more of Ang-(1-7) or less Ang II?
Carlos M. Ferrario
CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION (2011)
Angiotensin-converting enzyme 2 activation protects against hypertension-induced cardiac fibrosis involving extracellular signal-regulated kinases
Anderson J. Ferreira et al.
EXPERIMENTAL PHYSIOLOGY (2011)
The definition, classification, and prognosis of chronic kidney disease: a KDIGO Controversies Conference report
Andrew S. Levey et al.
KIDNEY INTERNATIONAL (2011)
CARDIOVASCULAR DISEASE World Kidney Day 2011: protect your kidneys, save your heart
William G. Couser et al.
NATURE REVIEWS NEPHROLOGY (2011)
Inhibition of Angiotensin-Converting Enzyme 2 Exacerbates Cardiac Hypertrophy and Fibrosis in Ren-2 Hypertensive Rats
Aaron J. Trask et al.
AMERICAN JOURNAL OF HYPERTENSION (2010)
Reduction in renal ACE2 expression in subtotal nephrectomy in rats is ameliorated with ACE inhibition
Elena Velkoska et al.
CLINICAL SCIENCE (2010)
Human Recombinant ACE2 Reduces the Progression of Diabetic Nephropathy
Gavin Y. Oudit et al.
DIABETES (2010)
The importance of the intrarenal renin-angiotensin system
Juan Carlos Q. Velez
NATURE CLINICAL PRACTICE NEPHROLOGY (2009)
ACE2 deficiency modifies renoprotection afforded by AGE inhibition in experimental diabetes
Chris Tikellis et al.
DIABETES (2008)
Differential regulation of renal angiotensin-converting enzyme (ACE) and ACE2 during ACE inhibition and dietary sodium restriction in healthy rats
I. Hamming et al.
EXPERIMENTAL PHYSIOLOGY (2008)
Acute kidney injury in the rat causes cardiac remodelling and increases angiotensin-converting enzyme 2 expression
L. Burchill et al.
EXPERIMENTAL PHYSIOLOGY (2008)
Structure-based identification of small-molecule angiotensin-converting enzyme 2 activators as novel antihypertensive agents
Jose A. Hernandez Prada et al.
HYPERTENSION (2008)
ACE2 overexpression inhibits hypoxia-induced collagen production by cardiac fibroblasts
Justin L. Grobe et al.
CLINICAL SCIENCE (2007)
Upregulation of hepatic angiotensin-converting enzyme 2 (ACE2) and angiotensin-(1-7) levels in experimental biliary fibrosis
Chandana B. Herath et al.
JOURNAL OF HEPATOLOGY (2007)
ACE2 inhibition worsens glomerular injury in association with increased ACE expression in streptozotocin-induced diabetic mice
M. J. Soler et al.
KIDNEY INTERNATIONAL (2007)
Loss of angiotensin-converting enzyme-2 (Ace2) accelerates diabetic kidney injury
Denise W. Wong et al.
AMERICAN JOURNAL OF PATHOLOGY (2007)
Glomerular localization and expression of angiotensin-converting enzyme 2 and angiotensin-converting enzyme: Implications for albuminuria in diabetes
Minghao Ye et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2006)
Effect of angiotensin II blockade on a new congenic model of hypertension derived from transgenic Ren-2 rats
Jewell A. Jessup et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2006)
ACE2 gene transfer attenuates hypertension-linked pathophysiological changes in the SHR
Carlos Diez-Freire et al.
PHYSIOLOGICAL GENOMICS (2006)
ACE and ACE2 activity in diabetic mice
Jan Wysocki et al.
DIABETES (2006)
Developmental expression of ACE2 in the SHR kidney: A role in hypertension?
C. Tikellis et al.
KIDNEY INTERNATIONAL (2006)
Loss of angiotensin-converting enzyme-2 leads to the late development of angiotensin II-dependent glomerulosclerosis
Gavin Y. Oudit et al.
AMERICAN JOURNAL OF PATHOLOGY (2006)
Advances in biochemical and functional roles of angiotensin-converting enzyme 2 and angiotensin-(1-7) in regulation of cardiovascular function
CM Ferrario et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2005)
Connective tissue growth factor and cardiac fibrosis after myocardial infarction
RG Dean et al.
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY (2005)
Membrane-associated zinc peptidase families: comparing ACE and ACE2
JL Guy et al.
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2005)
Organ-specific distribution of ACE2 mRNA and correlating peptidase activity in rodents
F Gembardt et al.
PEPTIDES (2005)
Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2
CM Ferrario et al.
CIRCULATION (2005)
Myocardial infarction increases ACE2 expression in rat and humans
LM Burrell et al.
EUROPEAN HEART JOURNAL (2005)
Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization
AS Go et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
ACE2, a new regulator of the renin-angiotensin system
LM Burrell et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2004)
Increased ACE 2 and decreased ACE protein in renal tubules from diabetic mice - A renoprotective combination?
MH Ye et al.
HYPERTENSION (2004)
Angiotensin-(1-7) is an endogenous ligand for the G protein-coupled receptor Mas
RAS Santos et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Vasopeptidase inhibition attenuates the progression of renal injury in subtotal nephrectomized rats
ZM Cao et al.
KIDNEY INTERNATIONAL (2001)
Intrarenal angiotensin and bradykinin peptide levels in the remnant kidney model of renal insufficiency
FE Mackie et al.
KIDNEY INTERNATIONAL (2001)
A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9
M Donoghue et al.
CIRCULATION RESEARCH (2000)
Share Paper
